Logo image of LION

LIONSGATE STUDIOS CORP (LION) Stock Fundamental Analysis

NYSE:LION - CA53626N1024 - Common Stock

6.2 USD
-0.1 (-1.59%)
Last: 9/4/2025, 5:12:17 PM
6.31 USD
+0.11 (+1.77%)
After Hours: 9/4/2025, 5:12:17 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LION. LION was compared to 79 industry peers in the Entertainment industry. LION may be in some trouble as it scores bad on both profitability and health. LION has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

LION had negative earnings in the past year.
In the past year LION has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: LION reported negative net income in multiple years.
In the past 5 years LION always reported negative operating cash flow.
LION Yearly Net Income VS EBIT VS OCF VS FCFLION Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

LION's Return On Assets of -2.70% is in line compared to the rest of the industry. LION outperforms 48.10% of its industry peers.
LION has a Return On Invested Capital of 4.15%. This is in the better half of the industry: LION outperforms 70.89% of its industry peers.
Industry RankSector Rank
ROA -2.7%
ROE N/A
ROIC 4.15%
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)-6.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LION Yearly ROA, ROE, ROICLION Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

The Operating Margin of LION (5.41%) is better than 67.09% of its industry peers.
Looking at the Gross Margin, with a value of 117.71%, LION belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
OM 5.41%
PM (TTM) N/A
GM 117.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LION Yearly Profit, Operating, Gross MarginsLION Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

0

2. Health

2.1 Basic Checks

LION has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LION Yearly Shares OutstandingLION Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
LION Yearly Total Debt VS Total AssetsLION Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

LION has an Altman-Z score of -0.20. This is a bad value and indicates that LION is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.20, LION is not doing good in the industry: 64.56% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.2
ROIC/WACCN/A
WACCN/A
LION Yearly LT Debt VS Equity VS FCFLION Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.36 indicates that LION may have some problems paying its short term obligations.
LION has a Current ratio of 0.36. This is amonst the worse of the industry: LION underperforms 87.34% of its industry peers.
LION has a Quick Ratio of 0.36. This is a bad value and indicates that LION is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of LION (0.36) is worse than 86.08% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.36
LION Yearly Current Assets VS Current LiabilitesLION Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M

More info and screens

2

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3100%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.62%

3.2 Future

The Earnings Per Share is expected to grow by 67.63% on average over the next years. This is a very strong growth
Based on estimates for the next years, LION will show a small growth in Revenue. The Revenue will grow by 1.89% on average per year.
EPS Next Y218.36%
EPS Next 2Y103.54%
EPS Next 3Y67.63%
EPS Next 5YN/A
Revenue Next Year-11.77%
Revenue Next 2Y1.56%
Revenue Next 3Y1.89%
Revenue Next 5YN/A

3.3 Evolution

LION Yearly Revenue VS EstimatesLION Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 2028 1B 2B 3B
LION Yearly EPS VS EstimatesLION Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0 0.1 0.2 0.3 0.4 0.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LION. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 13.60, the valuation of LION can be described as correct.
88.61% of the companies in the same industry are more expensive than LION, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.48, LION is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 13.6
LION Price Earnings VS Forward Price EarningsLION Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LION is valued cheaply inside the industry as 91.14% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.72
LION Per share dataLION EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10 -15

4.3 Compensation for Growth

LION's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LION's earnings are expected to grow with 67.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y103.54%
EPS Next 3Y67.63%

More info and screens

0

5. Dividend

5.1 Amount

LION does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIONSGATE STUDIOS CORP

NYSE:LION (9/4/2025, 5:12:17 PM)

After market: 6.31 +0.11 (+1.77%)

6.2

-0.1 (-1.59%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05
Inst Owners34.58%
Inst Owner Change783.53%
Ins Owners3.74%
Ins Owner Change-1802.63%
Market Cap1.80B
Analysts78.57
Price Target8.86 (42.9%)
Short Float %3.17%
Short Ratio3.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)303.17%
Min EPS beat(2)-20.6%
Max EPS beat(2)626.95%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.83%
Min Revenue beat(2)0.44%
Max Revenue beat(2)3.22%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.47%
PT rev (3m)-28.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.6
P/S 0.84
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 3.72
EPS(TTM)-0.2
EYN/A
EPS(NY)0.46
Fwd EY7.35%
FCF(TTM)-1.28
FCFYN/A
OCF(TTM)-1.25
OCFYN/A
SpS7.34
BVpS-3.73
TBVpS-15.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.7%
ROE N/A
ROCE 5.25%
ROIC 4.15%
ROICexc 4.53%
ROICexgc N/A
OM 5.41%
PM (TTM) N/A
GM 117.71%
FCFM N/A
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)-6.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 1.48
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.36
Altman-Z -0.2
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)0.51%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3100%
EPS Next Y218.36%
EPS Next 2Y103.54%
EPS Next 3Y67.63%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.62%
Revenue Next Year-11.77%
Revenue Next 2Y1.56%
Revenue Next 3Y1.89%
Revenue Next 5YN/A
EBIT growth 1Y331.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1414.8%
EBIT Next 3Y154.59%
EBIT Next 5Y102.23%
FCF growth 1Y-72843.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70899.5%
OCF growth 3YN/A
OCF growth 5YN/A